Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2018-05-07 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VILLEURBANNE (69100), Rhone
SELARL GRANDE PHARMACIE DES GRATTE-CIEL : revenue, balance sheet and financial ratios
SELARL GRANDE PHARMACIE DES GRATTE-CIEL is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLEURBANNE (69100),
this company of category PME
shows in 2022 a revenue of 7.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL GRANDE PHARMACIE DES GRATTE-CIEL (SIREN 839443348)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
7 892 967 €
7 168 404 €
6 397 082 €
9 334 685 €
Net income
289 269 €
183 035 €
589 500 €
411 415 €
259 714 €
-165 633 €
EBITDA
N/C
N/C
615 035 €
445 101 €
187 286 €
138 650 €
Net margin
N/C
N/C
7.5%
5.7%
4.1%
-1.8%
Revenue and income statement
In 2024, SELARL GRANDE PHARMACIE DES GRATTE-CIEL generates positive net income of 289 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
289 269 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 305%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 21%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
305.426%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
20.98%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL GRANDE PHARMACIE DES GRATTE-CIEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
-4741.475
4878.059
1093.095
449.523
390.474
305.426
Financial autonomy
-1.864
1.786
7.294
15.673
17.193
20.98
Repayment capacity
-37.373
22.461
12.162
7.877
None
None
Cash flow / Revenue
-1.775%
4.382%
6.777%
8.17%
None%
None%
Sector positioning
Debt ratio
305.432024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of SELARL GRANDE PHARMACIE D... (305.43) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
20.98%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of SELARL GRANDE PHARMACIE D... (21.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
7.88 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELARL GRANDE PHARMACIE D... (7.88) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 146.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
146.811
Liquidity indicators evolution SELARL GRANDE PHARMACIE DES GRATTE-CIEL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
124.511
180.435
173.424
152.456
125.123
146.811
Interest coverage
94.422
35.403
12.096
10.758
None
None
Sector positioning
Liquidity ratio
146.812024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average
In 2024, the liquidity ratio of SELARL GRANDE PHARMACIE D... (146.81) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
10.76x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent
In 2022, the interest coverage of SELARL GRANDE PHARMACIE D... (10.8x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL GRANDE PHARMACIE DES GRATTE-CIEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Operating WCR
764 791 €
887 787 €
800 209 €
937 369 €
0 €
0 €
Inventory turnover (days)
28
45
40
38
0
0
Customer payment term (days)
5
7
8
10
0
0
Supplier payment term (days)
33
45
46
46
0
0
Positioning of SELARL GRANDE PHARMACIE DES GRATTE-CIEL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL GRANDE PHARMACIE DES GRATTE-CIEL is estimated at
4 038 409 €
(range 2 812 284€ - 6 041 691€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2812k€4038k€6041k€
4 038 409 €Range: 2 812 284€ - 6 041 691€
NAF 5 année 2024
Valuation method used
Net Income Multiple
289 269 €
×
14.0x
=4 038 409 €
Range: 2 812 284€ - 6 041 691€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL GRANDE PHARMACIE DES GRATTE-CIEL with other companies in the same sector:
Frequently asked questions about SELARL GRANDE PHARMACIE DES GRATTE-CIEL
What is the revenue of SELARL GRANDE PHARMACIE DES GRATTE-CIEL ?
The revenue of SELARL GRANDE PHARMACIE DES GRATTE-CIEL in 2022 is 7.9 M€.
Is SELARL GRANDE PHARMACIE DES GRATTE-CIEL profitable?
Yes, SELARL GRANDE PHARMACIE DES GRATTE-CIEL generated a net profit of 289 k€ in 2024.
Where is the headquarters of SELARL GRANDE PHARMACIE DES GRATTE-CIEL ?
The headquarters of SELARL GRANDE PHARMACIE DES GRATTE-CIEL is located in VILLEURBANNE (69100), in the department Rhone.
Where to find the tax return of SELARL GRANDE PHARMACIE DES GRATTE-CIEL ?
The tax return of SELARL GRANDE PHARMACIE DES GRATTE-CIEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL GRANDE PHARMACIE DES GRATTE-CIEL operate?
SELARL GRANDE PHARMACIE DES GRATTE-CIEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart